3.97 USD
+0.04 (+1.02%)
Taking everything into account, REAX scores 4 out of 10 in our fundamental rating. REAX was compared to 64 industry peers in the Real Estate Management & Development industry. While REAX has a great health rating, there are worries on its profitability. REAX is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year REAX has reported negative net income.
In the past year REAX had a positive cash flow from operations.
REAX had negative earnings in each of the past 5 years.
REAX had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -7.26%, REAX is doing worse than 67.19% of the companies in the same industry.
With a Return On Equity value of -19.66%, REAX is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.26% | ||
| ROE | -19.66% | ||
| ROIC | N/A |
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 8.64%, REAX is doing worse than 65.63% of the companies in the same industry.
REAX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for REAX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
2. Health
2.1 Basic Checks
REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REAX has more shares outstanding
REAX has more shares outstanding than it did 5 years ago.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
REAX has an Altman-Z score of 16.87. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.87, REAX belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
There is no outstanding debt for REAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.87 |
ROIC/WACCN/A
WACC8.7%
2.3 Liquidity
REAX has a Current Ratio of 1.36. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.36, REAX is in line with its industry, outperforming 40.63% of the companies in the same industry.
A Quick Ratio of 1.36 indicates that REAX should not have too much problems paying its short term obligations.
REAX has a Quick ratio (1.36) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 77.78% over the past year.
REAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 65.60%.
REAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 140.25% yearly.
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)65.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%52.64%
3.2 Future
Based on estimates for the next years, REAX will show a very strong growth in Earnings Per Share. The EPS will grow by 33.67% on average per year.
Based on estimates for the next years, REAX will show a very strong growth in Revenue. The Revenue will grow by 32.58% on average per year.
EPS Next Y65.39%
EPS Next 2Y36.84%
EPS Next 3Y33.67%
EPS Next 5YN/A
Revenue Next Year59.13%
Revenue Next 2Y39.55%
Revenue Next 3Y32.58%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
REAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year REAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
90.63% of the companies in the same industry are more expensive than REAX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.64 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
REAX's earnings are expected to grow with 33.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.84%
EPS Next 3Y33.67%
5. Dividend
5.1 Amount
REAX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:REAX (11/25/2025, 1:50:59 PM)
3.97
+0.04 (+1.02%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners37.27%
Inst Owner Change1.59%
Ins Owners11.55%
Ins Owner ChangeN/A
Market Cap830.92M
Revenue(TTM)1.81B
Net Income(TTM)-10.54M
Analysts86
Price Target6.46 (62.72%)
Short Float %1.54%
Short Ratio1.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)196.08%
Min EPS beat(2)100%
Max EPS beat(2)292.16%
EPS beat(4)4
Avg EPS beat(4)120.81%
Min EPS beat(4)34.64%
Max EPS beat(4)292.16%
EPS beat(8)6
Avg EPS beat(8)53.29%
EPS beat(12)8
Avg EPS beat(12)36.56%
EPS beat(16)11
Avg EPS beat(16)27.77%
Revenue beat(2)2
Avg Revenue beat(2)7.15%
Min Revenue beat(2)4.42%
Max Revenue beat(2)9.88%
Revenue beat(4)4
Avg Revenue beat(4)8.27%
Min Revenue beat(4)4.24%
Max Revenue beat(4)14.54%
Revenue beat(8)8
Avg Revenue beat(8)11.77%
Revenue beat(12)12
Avg Revenue beat(12)13.69%
Revenue beat(16)16
Avg Revenue beat(16)19.94%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-5.56%
EPS NY rev (3m)-35.71%
Revenue NQ rev (1m)2.71%
Revenue NQ rev (3m)3.47%
Revenue NY rev (1m)1.97%
Revenue NY rev (3m)3.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.46 | ||
| P/FCF | 12.64 | ||
| P/OCF | 11.95 | ||
| P/B | 15.49 | ||
| P/tB | 20.71 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.31
FCFY7.91%
OCF(TTM)0.33
OCFY8.37%
SpS8.67
BVpS0.26
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.26% | ||
| ROE | -19.66% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.64% | ||
| FCFM | 3.62% |
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score7
Asset Turnover12.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 219.19% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | 16.87 |
F-Score7
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)185.96%
Cap/Depr(5y)132.21%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y65.39%
EPS Next 2Y36.84%
EPS Next 3Y33.67%
EPS Next 5YN/A
Revenue 1Y (TTM)65.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%52.64%
Revenue Next Year59.13%
Revenue Next 2Y39.55%
Revenue Next 3Y32.58%
Revenue Next 5YN/A
EBIT growth 1Y65.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.04%
EBIT Next 3Y81.38%
EBIT Next 5YN/A
FCF growth 1Y210.23%
FCF growth 3Y133%
FCF growth 5YN/A
OCF growth 1Y214.26%
OCF growth 3Y131.26%
OCF growth 5YN/A
REAL BROKERAGE INC/THE / REAX FAQ
What is the fundamental rating for REAX stock?
ChartMill assigns a fundamental rating of 4 / 10 to REAX.
What is the valuation status of REAL BROKERAGE INC/THE (REAX) stock?
ChartMill assigns a valuation rating of 2 / 10 to REAL BROKERAGE INC/THE (REAX). This can be considered as Overvalued.
What is the profitability of REAX stock?
REAL BROKERAGE INC/THE (REAX) has a profitability rating of 1 / 10.
Can you provide the financial health for REAX stock?
The financial health rating of REAL BROKERAGE INC/THE (REAX) is 7 / 10.
Can you provide the expected EPS growth for REAX stock?
The Earnings per Share (EPS) of REAL BROKERAGE INC/THE (REAX) is expected to grow by 65.39% in the next year.